Top
SYPL2 has not been detected as a mutational cancer driver

SYPL2
Ensembl id ENSG00000143028
Mutated samples
Coding Sequence 46 (0.7%)
Protein Affecting 18 (0.3%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all SYPL2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 15 6 1.63
Lung adenocarcinoma No 5 3 0.77
Breast carcinoma No 4 2 0.17
Head and neck squamous cell carcinoma No 5 2 0.53
Pancreas adenocarcinoma No 1 1 0.47
Renal clear cell carcinoma No 2 1 0.24
Small cell lung carcinoma No 2 1 1.45
Colorectal adenocarcinoma No 1 1 0.44
Esophageal carcinoma No 2 1 0.68
Hepatocarcinoma No 1 0 0.00
Bladder carcinoma No 1 0 0.00
Acute myeloid leukemia No 1 0 0.00
Lung squamous cell carcinoma No 1 0 0.00
Uterine corpus endometrioid carcinoma No 3 0 0.00
Serous ovarian adenocarcinoma No 1 0 0.00
Stomach adenocarcinoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence